CDKN1A and neoplasm: At the basis of these behaviors are mechanisms (e.g., phosphorylation) allowing p21 to shift localization from the nucleus to the cytoplasm, where it can inhibit apoptosis [15], thereby facilitating the escape of tumor cells from drug-induced cell death [16,17].